Ameriprise’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-291,870
| Closed | -$1.17M | – | 3795 |
|
|
2019
Q4 | $1.17M | Sell |
291,870
-9,485
| -3% | -$44.6K | ﹤0.01% | 2993 |
|
|
2019
Q3 | $1.48M | Sell |
301,355
-5,437
| -2% | -$30.4K | ﹤0.01% | 2839 |
|
|
2019
Q2 | $1.87M | Sell |
306,792
-4,873
| -2% | -$25.9K | ﹤0.01% | 2792 |
|
|
2019
Q1 | $1.81M | Sell |
311,665
-11,237
| -3% | -$116K | ﹤0.01% | 2785 |
|
|
2018
Q4 | $4.35M | Sell |
322,902
-1,059
| -0.3% | -$17.9K | ﹤0.01% | 2213 |
|
|
2018
Q3 | $6.29M | Buy |
323,961
+43,106
| +15% | +$918K | ﹤0.01% | 2199 |
|
|
2018
Q2 | $7.18M | Buy |
280,855
+925
| +0.3% | +$21.6K | ﹤0.01% | 1986 |
|
|
2018
Q1 | $5.64M | Sell |
279,930
-243,370
| -47% | -$5.68M | ﹤0.01% | 2088 |
|
|
2017
Q4 | $10.5M | Buy |
523,300
+256,371
| +96% | +$5.04M | ﹤0.01% | 1579 |
|
|
2017
Q3 | $5.53M | Sell |
266,929
-6,050
| -2% | -$102K | ﹤0.01% | 2019 |
|
|
2017
Q2 | $4.04M | Buy |
272,979
+44,135
| +19% | +$736K | ﹤0.01% | 2238 |
|
|
2017
Q1 | $3.65M | Sell |
228,844
-8,218
| -3% | -$119K | ﹤0.01% | 2262 |
|
|
2016
Q4 | $2.99M | Sell |
237,062
-76,834
| -24% | -$1.43M | ﹤0.01% | 2419 |
|
|
2016
Q3 | $8.79M | Buy |
313,896
+64,108
| +26% | +$2.15M | ﹤0.01% | 1564 |
|
|
2016
Q2 | $8.74M | Buy |
249,788
+10,236
| +4% | +$322K | 0.01% | 1497 |
|
|
2016
Q1 | $6.56M | Buy |
239,552
+155,347
| +184% | +$4.57M | ﹤0.01% | 1761 |
|
|
2015
Q4 | $2.88M | Buy |
84,205
+35,748
| +74% | +$1.12M | ﹤0.01% | 2407 |
|
|
2015
Q3 | $1.39M | Sell |
48,457
-122,615
| -72% | -$5.24M | ﹤0.01% | 2819 |
|
|
2015
Q2 | $7.65M | Sell |
171,072
-81,358
| -32% | -$3.06M | ﹤0.01% | 1812 |
|
|
2015
Q1 | $8.73M | Sell |
252,430
-96,573
| -28% | -$2.63M | 0.01% | 1671 |
|
|
2014
Q4 | $9.55M | Buy |
+349,003
| New | +$8.47M | 0.01% | 1541 |
|
Other funds holding DPLO
Ameriprise's DPLO Position: Q1 2020 in Review
Ameriprise sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 291,870 shares — an estimated $1.17M sold.
Ameriprise first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $10.5M in Q4 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Ameriprise reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Ameriprise sold 291,870 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.17M.
- Ameriprise first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Ameriprise's DIPLOMAT PHARMACY, INC. position peaked at $10.5M in Q4 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.